Individuals Discontinuing Slimming Medications Regain Weight Far More Rapidly Compared to Those on Conventional Diets

Fresh analysis suggests that patients who come off popular slimming jabs like Mounjaro or Wegovy may regain lost weight much more quickly than those who end traditional lifestyle plans.

Research printed in a leading health publication demonstrates that while obese individuals frequently drop substantial amounts of their body weight while using the jabs, the weight is regained at an average rate of 0.8 kg per month once they quit.

"Users purchasing such medications should be informed of the risk of quick weight regain when the medication concludes," warns expert Dr. Susan Jebb.

This pace of regain means a return to starting mass in about one and a half years.

Weighing Therapies

The research, which examined dozens of studies involving thousands of participants, contrasted the results of the injectable medications with older methods.

Researchers emphasize that people who lose weight through lifestyle changes alone typically see a slower weight regain—around 0.1 kg a month—once they finish.

Understanding the Fast Regain

Nutrition scientists propose the mode of action of the jabs accounts for the accelerated weight return.

These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.

"Long-term administration of the hormone levels far above than normal could lead to the system to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.

"Discontinuation of this GLP-1 'fix' results in appetite is unsuppressed, making overeating much more probable."

A Lifelong Condition?

Health authorities advise the jabs for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.

Professionals say that, due to the high risk of weight regain, the treatment is often life-long.

This perspective is supported by pharmaceutical companies, who note that the results "highlight the persistent character of excess weight," similar to managing diseases like diabetes.

User Testimonies

Users who have come off the jabs describe a intense resurgence of appetite.

"It felt as if something activating and you become extremely hungry," recalled one woman.

This difficulty is compounded if users have not adopted sustainable lifestyle or habit changes during treatment.

Widespread Use

Recent estimates indicate that a significant number of people in the UK have used these injections in the past year, with interest continuing to grow.

• Adoption is more common among women compared to men.
• The middle-aged demographic shows the highest usage rates.
• Many access the medications through private prescriptions rather than public health services.

Finally, experts stress that while these medications are potent tools for shedding pounds, they are not a standalone fix and long-term success relies on ongoing behavioural support.